UPDATE: Morgan Stanley Upgrades Regeneron Pharma (REGN) to Overweight
Tweet Send to a Friend
(Updated - September 9, 2022 5:35 AM EDT)
Morgan Stanley analyst Matthew Harrison upgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison upgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
